Akira Toyofuku Selected Research

Burning Mouth Syndrome (Syndrome, Burning Mouth)

1/2022	Careful use of clonazepam and alpha lipoid acid in burning mouth syndrome treatment.
1/2020	Real-world Discontinuation of Antidepressant Treatment in Patients with Burning Mouth Syndrome: A Chart Review.
1/2020	Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
1/2019	Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome.
9/2018	An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome.
1/2017	Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases.
1/2016	Low-dose aripiprazole for refractory burning mouth syndrome.
7/2011	Milnacipran dose-effect study in patients with burning mouth syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Toyofuku Research Topics

Disease

8	Burning Mouth Syndrome (Syndrome, Burning Mouth) 01/2022 - 07/2011
8	Pain (Aches) 01/2022 - 01/2003
4	Neuralgia (Stump Neuralgia) 12/2019 - 03/2012
3	Bites and Stings (Sting) 01/2021 - 09/2006
2	Chronic Pain 01/2022 - 01/2003
1	Toothache (Toothaches) 01/2022
1	Sleep Wake Disorders 01/2022
1	Constipation 01/2022
1	Hallucinations (Hallucination) 01/2022
1	olfactory reference syndrome 11/2021
1	Facial Pain (Myofacial Pain) 01/2020
1	Peripheral Nerve Injuries 12/2019
1	Hyperalgesia 12/2019
1	Hypersensitivity (Allergy) 12/2017
1	Trigeminal Nerve Injuries 09/2017
1	Foreign Bodies (Foreign Body) 01/2016
1	Fibromyalgia (Fibrositis) 07/2004
1	Glossalgia (Glossodynia) 01/2003

Drug/Important Bio-Agent (IBA)

7	Amitriptyline (Elavil)FDA LinkGeneric 01/2022 - 01/2017
5	Aripiprazole (Abilify)FDA Link 01/2022 - 01/2016
5	Milnacipran (Ixel)FDA Link 01/2020 - 01/2003
4	Antidepressive Agents (Antidepressants)IBA 01/2020 - 01/2003
2	Mirtazapine (Rexer)FDA LinkGeneric 01/2020 - 03/2019
2	Calcitonin Gene-Related PeptideIBA 12/2017 - 09/2017
2	Glial Fibrillary Acidic ProteinIBA 09/2017 - 03/2012
1	AcidsIBA 01/2022
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2022
1	ORALIT (ORS)IBA 11/2021
1	ethyl loflazepateIBA 01/2020
1	Dental Implants (Dental Implant)IBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2019
1	Insulin (Novolin)FDA Link 12/2019
1	2,2-dimethylpropionic acid 3- (2- chloro- 6- methylaminopurin- 9- yl)- 2- (2,2- dimethylpropionyloxymethyl)propyl esterIBA 12/2017
1	2-methylthioadenosineIBA 12/2017
1	Purinergic P2Y Receptor AntagonistsIBA 12/2017
1	SaltsIBA 12/2017
1	Mitogen-Activated Protein Kinase 3IBA 12/2017
1	methylthio-ADPIBA 12/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2017
1	NeuropeptidesIBA 09/2017
1	PowdersIBA 01/2016
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2003
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2003
1	Serotonin (5 Hydroxytryptamine)IBA 01/2003

Therapy/Procedure

1	Retreatment 01/2021
1	Dental Occlusion 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Operative Surgical Procedures 01/2016
1	Local Anesthesia 01/2012